Literature DB >> 22161114

Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients.

Chi-Ming Tai1, Chih-Kun Huang, Jau-Chung Hwang, Hung Chiang, Chi-Yang Chang, Ching-Tai Lee, Ming-Lung Yu, Jaw-Town Lin.   

Abstract

BACKGROUND: Obesity is a risk factor for nonalcoholic fatty liver disease (NAFLD), which appears to improve after weight loss induced by bariatric surgery in Western countries. The present study aims to determine the alterations of clinical measurements and liver histology of NAFLD after bariatric surgery in morbidly obese Chinese patients.
METHODS: Between November 2006 and December 2007, 21 morbidly obese patients receiving intra-operative liver biopsy and follow-up liver biopsy 1 year after laparoscopic Roux-en-Y gastric bypass were enrolled. NAFLD activity score (NAS) and fibrosis stage were histologically evaluated.
RESULTS: The mean body mass index fell from 43.8 ± 7.5 to 28.3 ± 4.6 kg/m(2) (P < 0.01). Biochemical improvement was found in serum levels of alanine aminotransferase (P < 0.01) and γ-glutamyltransferase (P < 0.01), but not aspartate aminotransferase (P = 0.66). Histological improvement was noted in NAS (P < 0.01) and individual components, including steatosis (P < 0.01), ballooning degeneration (P < 0.01), and lobular inflammation (P = 0.02). Pre-operatively, 4 (19.0%), 11 (52.4%), and 6 (28.6%) patients were found to have NAS >/=5, 3 or 4, and </=2, respectively. All patients had NAS </=2 after surgery. Fibrosis stage also showed significant improvement (P < 0.01).
CONCLUSIONS: Bariatric surgery can achieve a dramatic improvement of NAFLD both biochemically and histologically in morbidly obese Chinese patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22161114     DOI: 10.1007/s11695-011-0579-7

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  25 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

Review 2.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

3.  Histological findings in the liver before and after gastric bypass.

Authors:  Attila Csendes; Gladys Smok; Ana Maria Burgos
Journal:  Obes Surg       Date:  2006-05       Impact factor: 4.129

4.  Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery.

Authors:  Kevin B Barker; Nicole A Palekar; Steven P Bowers; Joel E Goldberg; Joseph P Pulcini; Stephen A Harrison
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

5.  Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery.

Authors:  Cláudio Corá Mottin; Myriam Moretto; Alexandre Vontobel Padoin; Carlos Kupski; Aline Maria Swarowsky; Luiz Glock; Vinicius Duval; Jefferson Braga da Silva
Journal:  Obes Surg       Date:  2005 Jun-Jul       Impact factor: 4.129

6.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

7.  Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.

Authors:  Jeanne M Clark; Amir R A Alkhuraishi; Steven F Solga; Patricia Alli; Anna Mae Diehl; Thomas H Magnuson
Journal:  Obes Res       Date:  2005-07

Review 8.  Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis.

Authors:  Rajasekhara R Mummadi; Krishna S Kasturi; Swapna Chennareddygari; Gagan K Sood
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-19       Impact factor: 11.382

9.  Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity.

Authors:  Soraya Rodrigues de Almeida; Paulo Roberto Savassi Rocha; Marcelo Dias Sanches; Virgínia Hora Rios Leite; Rogério Augusto Pinto da Silva; Marco Túlio Costa Diniz; Maria de Fátima Haueisen Sander Diniz; Alexandre Lages Savassi Rocha
Journal:  Obes Surg       Date:  2006-03       Impact factor: 4.129

10.  Resolution of nonalcoholic steatohepatits after gastric bypass surgery.

Authors:  Xiuli Liu; Audrey J Lazenby; Ronald H Clements; Nirag Jhala; Gary A Abrams
Journal:  Obes Surg       Date:  2007-04       Impact factor: 4.129

View more
  27 in total

1.  Performance of the Bard Scoring System in Bariatric Surgery Patients with Nonalcoholic Fatty Liver Disease.

Authors:  André Thá Nassif; Thais Ayumi Nagano; Sulamita Okayama; Luís Sérgio Nassif; Alcides Branco Filho; José Sampaio Neto
Journal:  Obes Surg       Date:  2017-02       Impact factor: 4.129

2.  Rapid Reversal of Liver Steatosis With Life Style Modification in Highly Motivated Liver Donors.

Authors:  Narendra S Choudhary; Neeraj Saraf; Sanjiv Saigal; Dheeraj Gautam; Lipika Lipi; Amit Rastogi; Sanjay Goja; Palat B Menon; Prashant Bhangui; Sumana K Ramchandra; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2015-04-21

3.  Clinical Characteristics and Outcome of Morbidly Obese Bariatric Patients with Concurrent Hepatitis C Viral Infection.

Authors:  Ming-Lun Han; Wei-Jei Lee; Jung-Chien Chen; Kong-Han Ser; Shu-Chun Chen; Yi-Chih Lee
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

4.  Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study.

Authors:  Everton Cazzo; Laísa Simakawa Jimenez; José Carlos Pareja; Elinton Adami Chaim
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

Review 5.  Pathobiology of liver fibrosis: a translational success story.

Authors:  Youngmin A Lee; Michael C Wallace; Scott L Friedman
Journal:  Gut       Date:  2015-02-13       Impact factor: 23.059

6.  Evolution of Liver Steatosis Quantified by MR Imaging and MR Spectroscopy, in Morbidly Obese Patients Undergoing Sleeve Gastrectomy: Short-Term Outcomes.

Authors:  María Engracia Alsina; Jaime Ruiz-Tovar; Angela Bernabeu
Journal:  Obes Surg       Date:  2017-07       Impact factor: 4.129

Review 7.  Nonmedicinal interventions in nonalcoholic fatty liver disease.

Authors:  Manuela G Neuman; Radu M Nanau; Lawrence B Cohen
Journal:  Can J Gastroenterol Hepatol       Date:  2015 Jun-Jul

8.  Laparoscopic Sleeve Gastrectomy on the Horizon as a Promising Treatment Modality for NAFLD.

Authors:  Mohamed Abdalla Salman; Ahmed Abdallah Salman; Ahmed Abdelsalam; Mohamed Atallah; Hossam El-Din Shaaban; Ahmed El-Mikkawy; Mahmoud Gouda Omar; Mai Elshenoufy
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

Review 9.  Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.

Authors:  Guy Bower; Tania Toma; Leanne Harling; Long R Jiao; Evangelos Efthimiou; Ara Darzi; Thanos Athanasiou; Hutan Ashrafian
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

10.  Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Geraldine J Ooi; Paul R Burton; Lisa Doyle; John M Wentworth; Prithi S Bhathal; Ken Sikaris; Michael A Cowley; Stuart K Roberts; William Kemp; Arul Earnest; Paul E O'Brien; Wendy A Brown
Journal:  Obes Surg       Date:  2017-06       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.